Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018

Go back to Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018

Alkermes (ALKS) PT Raised to $70 at Credit Suisse; 'While 4230 Excites the Street, We Look for Progress With Vivitrol and 5461'

February 16, 2018 8:30 AM EST

Credit Suisse raised its price target on Alkermes (NASDAQ: ALKS) to $70.00 (from $66.00) while maintaining a Outperform rating.

... More

Alkermes plc (ALKS) Tops Q4 EPS by 7c, Offers Guidance

February 14, 2018 7:11 AM EST

Alkermes plc (NASDAQ: ALKS) reported Q4 EPS of $0.31, $0.07 better than the analyst estimate of $0.24. Revenue for the quarter came in at $275.4 million versus the consensus estimate of $252.92 million.

GUIDANCE:

Alkermes plc sees FY2018 EPS of ($0.03)-($0.23), versus the consensus of... More